To gain further insight into the influence of C1GalT1 change on tumour cell activities mediated by galectin-3 and MGL, we further analysed the cell surface binding receptors of galectin-3 and MGL in response to change of C1GalT expression in cancer cells. The gene discussed is CLEC10A; the disease is cancer.